TAP reading note: Acute sleep rebound following sleep restriction is associated with reduced mortality risk

What the study found

Mortality associations differed across restriction/rebound patterns; rebound groups were not significantly different from regular sleep.

Scope & limitations

85,618 UK Biobank participants; replication in 4,586 NHANES participants.

Observational; rebound is not specifically weekend sleep. Non-significance does not establish equivalence or causation.

Population & sample

85,618 UK Biobank participants; replication in 4,586 NHANES participants.

Exposure or intervention

Accelerometer-derived restriction and subsequent rebound.

Outcomes

Mortality associations.

Time frame

Median UK Biobank follow-up: 8.0 years.

Research funding

No specific study funding statement was identified in the consulted main text.

Research conflicts of interest

M. K. Rutter: Eli Lilly consulting and modest GSK holdings, reported as unrelated. S. Redline: Eli Lilly consulting, Sleep Health editorship, unpaid National Sleep Foundation and Alliance of Sleep Apnea Partners board roles. Others declared no competing interests.

Reading scope

Publisher full text: methods, results and declarations.

References

1. Xiaoyu Li, Manrui Zhang, Zhenyu Li, Shengkui Zhang, Suzanne M. Bertisch, Tianyi Huang, Martin K. Rutter, Susan Redline (2026). Acute sleep rebound following sleep restriction is associated with reduced mortality risk. Nature Communications. https://doi.org/10.1038/s41467-026-72461-1

Publication record

TAP-RDN-0043 · v1.0 · English

Author: TAP Editorial Team ·

The Allostasis Project is founded and supported by Resilio.

© The Allostasis Project. All rights reserved. Reproduction or adaptation requires separate permission, subject to applicable legal exceptions.

Download complete edition record (JSON) ↧